Chief Pharmacist, Director of the Department of Clinical Pharmacy. Specialties: precision medication for rhinitis and sinusitis, medication for adenoid hypertrophy, pharmacotherapy for respiratory diseases such as asthma and pneumonia, administration of antibiotics and hormones in children, reduction of adverse drug reactions, and individualized medication. With 18 years of experience in pediatric clinical pharmacy services, he has in-depth expertise in ensuring the safety and precision of pediatric medication.

Main research directions: pediatric medication safety, mechanisms of drug-induced renal injury, pharmacogenomics, individualized pediatric medication, population pharmacokinetics, etc. He has presided over 25 research projects including those funded by the National Natural Science Foundation of China, Shanghai Science and Technology Commission and Shanghai Health Commission. As the first or corresponding author, he has published 40 SCI papers (12 in JCR Q1 journals with the highest impact factor of 20.69), obtained 5 authorized patents, and served as the chief editor of 6 books. He is the associate editor of the online version of China Pharmacy, youth editorial board member of Chinese Pharmacological Bulletin, and guest editor of Pharmacological Research.

Overseas training experience: Visiting Scholar at Boston Children's Hospital, Harvard University; received further training in pediatric clinical pharmacy technology and pharmacogenomics at Rhode Island Hospital affiliated to Brown University and UC San Diego in the United States.